Myosin Light Chain Kinase Signaling in Endothelial Barrier Dysfunction: MLCK SIGNALING IN ENDOTHELIAL BARRIER DYSFUNCTION
Open accessThe DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
Microvascular barrier dysfunction is a serious problem that occurs in many inflammatory conditions, including sepsis, trauma, ischemia-reperfusion injury, cardiovascular disease, and diabetes. Barrier dysfunction permits extravasation of serum components into the surrounding tissue, leading to edema formation and organ failure. The basis for microvascular barrier dysfunction is hyperpermeability at endothelial cell-cell junctions. Endothelial hyperpermeability is increased by actomyosin contractile activity in response to phosphorylation of myosin light chain by myosin light chain kinase (MLCK). MLCK-dependent endothelial hyperpermeability occurs in response to inflammatory mediators (e.g., activated neutrophils, thrombin, histamine, tumor necrosis factor alpha, etc.), through multiple cell signaling pathways and signaling molecules (e.g., Ca(++) , protein kinase C, Src kinase, nitric oxide synthase, etc.). Other signaling molecules protect against MLCK-dependent hyperpermeability (e.g., sphingosine-1-phosphate or cAMP). In addition, individual MLCK isoforms play specific roles in endothelial barrier dysfunction, suggesting that isoform-specific inhibitors could be useful for treating inflammatory disorders and preventing multiple organ failure. Because endothelial barrier dysfunction depends upon signaling through MLCK in many instances, MLCK-dependent signaling comprises multiple potential therapeutic targets for preventing edema formation and multiple organ failure. The following review is a discussion of MLCK-dependent mechanisms and cell signaling events that mediate endothelial hyperpermeability.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The blood-brain barrier/neurovascular unit in health and disease
Hawkins, B. T., & Davis, T. P. (2005) · Pharmacological Reviews · doi:10.1124/pr.57.2.4 · Cited by 2,661
Cellular mechanisms of IL-17-induced blood-brain barrier disruption
Huppert, J., Closhen, D., Croxford, A., White, R., Kulig, P., Pietrowski, E., Bechmann, I., Becher, B., Luhmann, H. J., Waisman, A., et al. (2010) · The FASEB Journal · doi:10.1096/fj.09-141978 · Cited by 529
Aveleira, C. A., Lin, C.-M., Abcouwer, S. F., Ambrósio, A. F., & Antonetti, D. A. (2010) · Diabetes · doi:10.2337/db09-1606 · Cited by 403
Endothelial Mitochondria: Contributing to Vascular Function and Disease
Davidson, S. M., & Duchen, M. R. (2007) · Circulation Research · doi:10.1161/01.res.0000261970.18328.1d · Cited by 381
Schreibelt, G., Kooij, G., Reijerkerk, A., van Doorn, R., Gringhuis, S. I., van der Pol, S., Weksler, B. B., Romero, I. A., Couraud, P., Piontek, J., et al. (2007) · The FASEB Journal · doi:10.1096/fj.07-8329com · Cited by 347
Reed, R. K., & Rubin, K. (2010) · Cardiovascular Research · doi:10.1093/cvr/cvq143 · Cited by 209
Cai, H., Davis, M. E., Drummond, G. R., & Harrison, D. G. (2001) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/hq1001.097028 · Cited by 160
Mechanisms of C-Reactive Protein-Induced Blood–Brain Barrier Disruption
Kuhlmann, C. R. W., Librizzi, L., Closhen, D., Pflanzner, T., Lessmann, V., Pietrzik, C. U., de Curtis, M., & Luhmann, H. J. (2009) · Stroke · doi:10.1161/strokeaha.108.535930 · Cited by 138
TRPC-mediated actin-myosin contraction is critical for BBB disruption following hypoxic stress
Hicks, K., O'Neil, R. G., Dubinsky, W. S., & Brown, R. C. (2010) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00458.2009 · Cited by 70
Cioffi, D. L., Barry, C., & Stevens, T. (2010) · Advances in Experimental Medicine and Biology · doi:10.1007/978-1-60761-500-2_9 · Cited by 41
Cited by
IL-1β and the Intestinal Epithelial Tight Junction Barrier
Kaminsky, L. W., Al-Sadi, R., & Ma, T. Y. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.767456 · Cited by 432
The Roles of Glutamine in the Intestine and Its Implication in Intestinal Diseases
Kim, M.-H., & Kim, H. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18051051 · Cited by 371
Rajeev, V., Fann, D. Y., Dinh, Q. N., Kim, H. A., De Silva, T. M., Lai, M. K. P., Chen, C. L.-H., Drummond, G. R., Sobey, C. G., & Arumugam, T. V. (2022) · Theranostics · doi:10.7150/thno.68304 · Cited by 296
Mechanisms Regulating Endothelial Permeability
Sukriti, S., Tauseef, M., Yazbeck, P., & Mehta, D. (2014) · Pulmonary Circulation · doi:10.1086/677356 · Cited by 283
Mannose ameliorates experimental colitis by protecting intestinal barrier integrity
Dong, L., Xie, J., Wang, Y., Jiang, H., Chen, K., Li, D., Wang, J., Liu, Y., He, J., Zhou, J., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-32505-8 · Cited by 261
Metadata
- Authors
- Rigor, R. R., Shen, Q., Pivetti, C. D., Wu, M. H., & Yuan, S. Y.
- Venue
- Medicinal Research Reviews
- Publisher
- Wiley
- Published
- 2012-08-09
- Volume
- 33
- Issue
- 5
- Pages
- 911-933
- ISSN
- 0198-6325 (ISSN-L)
- OpenAlex
- W1498314202
- Cited by
- 130
- References
- 10
- FWCI
- 3.66
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Myosin Light Chain Kinase Signaling in Endothelial Barrier Dysfunction: MLCK SIGNALING IN ENDOTHELIAL BARRIER DYSFUNCTION. https://app.cochat.ai/papers/10.1002/med.21270
- The paper
- Rigor, R. R., Shen, Q., Pivetti, C. D., Wu, M. H., & Yuan, S. Y. (2013). Myosin Light Chain Kinase Signaling in Endothelial Barrier Dysfunction: MLCK SIGNALING IN ENDOTHELIAL BARRIER DYSFUNCTION. Medicinal Research Reviews. https://doi.org/10.1002/med.21270
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.